Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


27.03.2017

1 Am J Surg Pathol
1 Blood
1 Br J Dermatol
1 Int J Radiat Oncol Biol Phys
1 Lancet Oncol
4 Leuk Lymphoma
1 Leukemia
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. LI M, Liu Y, Wang Y, Chen G, et al
    Anaplastic Variant of Diffuse Large B-cell Lymphoma Displays Intricate Genetic Alterations and Distinct Biological Features.
    Am J Surg Pathol. 2017 Mar 17. doi: 10.1097/PAS.0000000000000836.
    PubMed     Text format     Abstract available


    Blood

  2. GOPAL AK, Kahl BS, Flowers CR, Martin P, et al
    Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
    Blood. 2017 Mar 21. pii: blood-2016-12-757740. doi: 10.1182/blood-2016-12-757740
    PubMed     Text format    


    Br J Dermatol

  3. LECAMWASAM K, Mathew B, Gilson D, Burton C, et al
    Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al.
    Br J Dermatol. 2016;174:1158-9.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  4. RIMNER A, Lovie S, Hsu M, Chelius M, et al
    Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.
    Int J Radiat Oncol Biol Phys. 2017;97:1066-1076.
    PubMed     Text format     Abstract available


    Lancet Oncol

  5. DAS M
    Nivolumab activity in relapsed Hodgkin's lymphoma.
    Lancet Oncol. 2017 Mar 16. pii: S1470-2045(17)30195.
    PubMed     Text format    


    Leuk Lymphoma

  6. CEDERLEUF H, Hjort Jakobsen L, Ellin F, de Nully Brown P, et al
    Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.
    Leuk Lymphoma. 2017 Mar 20:1-9. doi: 10.1080/10428194.2017.1300888.
    PubMed     Text format     Abstract available

  7. BORCHMANN S, von Tresckow B
    Novel agents in classical Hodgkin lymphoma.
    Leuk Lymphoma. 2017 Mar 20:1-12. doi: 10.1080/10428194.2017.1300898.
    PubMed     Text format     Abstract available

  8. YOON KA, Kim MK, Eom HS, Lee H, et al
    Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2017 Mar 22:1-6. doi: 10.1080/10428194.2017.1300893.
    PubMed     Text format     Abstract available

  9. KOSTOS L, Chai KL, Tam CS, Bazargan A, et al
    The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2017 Mar 23:1-4. doi: 10.1080/10428194.2017.1281414.
    PubMed     Text format    


    Leukemia

  10. DZIKIEWICZ-KRAWCZYK A, Kok K, Slezak-Prochazka I, Robertus JL, et al
    ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.
    Leukemia. 2017 Mar 23. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    PLoS One

  11. FLETCHER LB, Veenstra RN, Loo EY, Hwang AE, et al
    HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    PLoS One. 2017;12:e0174457.
    PubMed     Text format     Abstract available

  12. ZHANG Y, Zhang R, Ding X, Peng B, et al
    FNC efficiently inhibits mantle cell lymphoma growth.
    PLoS One. 2017;12:e0174112.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: